|
Katz, Y; Weizman, A; Pick, C G et al. (1994) Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity. Brain Res 646:235-41
|
|
Pick, C G; Nejat, R J; Pasternak, G W (1993) Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J Pharmacol Exp Ther 265:166-71
|
|
Rossi, G C; Pasternak, G W; Bodnar, R J (1993) Synergistic brainstem interactions for morphine analgesia. Brain Res 624:171-80
|
|
Pick, C G; Paul, D; Eison, M S et al. (1992) Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 211:375-81
|
|
Standifer, K M; Murthy, L R; Kinouchi, K et al. (1991) Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone. Mol Pharmacol 39:290-8
|
|
Pick, C G; Paul, D; Pasternak, G W (1991) Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions. Life Sci 48:2005-11
|
|
Kinouchi, K; Pasternak, G W (1991) Evidence for kappa 1 opioid receptor multiplicity in the guinea pig cerebellum. Eur J Pharmacol 207:135-41
|
|
Mann, P E; Pasternak, G W; Bridges, R S (1990) Mu 1 opioid receptor involvement in maternal behavior. Physiol Behav 47:133-8
|
|
Bodnar, R J; Paul, D; Pasternak, G W (1990) Proglumide selectively potentiates supraspinal mu 1 opioid analgesia in mice. Neuropharmacology 29:507-10
|
|
Paul, D; Levison, J A; Howard, D H et al. (1990) Naloxone benzoylhydrazone (NalBzoH) analgesia. J Pharmacol Exp Ther 255:769-74
|
Showing the most recent 10 out of 11 publications
